Cargando…
Capturing the real‐world benefit of residual β‐cell function during clinically important time‐periods in established Type 1 diabetes
AIMS: Many individuals with type 1 diabetes retain residual β‐cell function, with increased endogenous insulin secretion associated with reduced hyperglycaemia, hypoglycaemia and glycaemic variability. However, it is unknown when these improvements occur during the day. Dysglycaemia is common in ove...
Autores principales: | Taylor, Guy S., Shaw, Andy C., Smith, Kieran, Wason, James, McDonald, Timothy J., Oram, Richard A., Stevenson, Emma, Shaw, James A. M., West, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311680/ https://www.ncbi.nlm.nih.gov/pubmed/35181926 http://dx.doi.org/10.1111/dme.14814 |
Ejemplares similares
-
Bone turnover and metabolite responses to exercise in people with and without long-duration type 1 diabetes: a case–control study
por: Taylor, Guy S, et al.
Publicado: (2020) -
Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes
por: Sasongko, Muhammad Bayu, et al.
Publicado: (2012) -
Age-Period-Cohort Analysis of 1990–2003 Incidence Time Trends of Childhood Diabetes in Italy: The RIDI Study
por: Bruno, Graziella, et al.
Publicado: (2010) -
How low is really low? Comparison of two C‐peptide assays to establish residual C‐peptide production in type 1 diabetes
por: de Leur, Kitty, et al.
Publicado: (2022) -
Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors
por: Alatrach, Mariam, et al.
Publicado: (2020)